Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

被引:62
作者
Radfar, Seyed Ramin [1 ,2 ]
De Jong, Cornelis A. J. [3 ]
Farhoudian, Ali [4 ]
Ebrahimi, Mohsen [5 ,6 ]
Rafei, Parnian [7 ]
Vahidi, Mehrnoosh [4 ]
Yunesian, Masud [8 ]
Kouimtsidis, Christos [9 ]
Arunogiri, Shalini [10 ]
Massah, Omid [11 ]
Deylamizadeh, Abbas [12 ]
Brady, Kathleen T. [13 ]
Busse, Anja [14 ]
Potenza, Marc N. [15 ]
Ekhtiari, Hamed [16 ,17 ]
Baldacchino, Alexander Mario [18 ]
机构
[1] Univ Tehran Med Sci, Sch Adv Technol Med SATiM, Dept Neurosci & Addict, Tehran, Iran
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs Dept, Los Angeles, CA USA
[3] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands
[4] Univ Tehran Med Sci, Dept Psychiat, Tehran, Iran
[5] Mat & Energy Res Ctr, Tehran, Iran
[6] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Tehran, Iran
[7] Univ Tehran, Fac Psychol & Educ, Dept Psychol, Tehran, Iran
[8] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran
[9] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England
[10] Eastern Hlth, Turning Point, Box Hill, Vic, Australia
[11] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Tehran, Iran
[12] Rebirth Char Soc NGO, Tehran, Iran
[13] Med Univ South Carolina, Charleston, SC 29425 USA
[14] United Nations Off Drugs & Crime, Drug Prevent & Hlth Branch, Div Operat, Prevent Treatment & Rehabil Sect, Vienna, Austria
[15] Yale Sch Med, Connecticut Council Problem Gambling, New Haven, CT USA
[16] Yale Sch Med, Connecticut Mental Hlth Ctr, New Haven, CT USA
[17] Laureate Inst Brain Res, Tulsa, OK USA
[18] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 12卷
关键词
COVID-19; pandemic; substance use disorder; public health; drug policy; opioid agonist treatment; addiction services; harm reduction; CLIMATE-CHANGE; USE DISORDER; PEOPLE; VULNERABILITY; IMMUNITY; STRESS; IMPACT;
D O I
10.3389/fpsyt.2021.639393
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Survey on the use of general practice telehealth services for children during the COVID-19 pandemic
    Ramanathan, Ashwin
    Ramanathan, Paddy
    Saha, Amit
    AUSTRALIAN JOURNAL OF PRIMARY HEALTH, 2022, 28 (06) : 529 - 534
  • [42] Substance and Internet use during the COVID-19 pandemic in China
    Huang, Qiuping
    Chen, Xinxin
    Huang, Shucai
    Shao, Tianli
    Liao, Zhenjiang
    Lin, Shuhong
    Li, Yifan
    Qi, Jing
    Cai, Yi
    Shen, Hongxian
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [43] Alcohol and other substance use during the COVID-19 pandemic: A systematic review
    Roberts, Amanda
    Rogers, Jim
    Mason, Rachael
    Siriwardena, Aloysius Niroshan
    Hogue, Todd
    Whitley, Gregory Adam
    Law, Graham R.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 229
  • [44] Exploring Factors Associated with Alcohol and/or Substance Use During the COVID-19 Pandemic
    MacMillan, Thalia
    Corrigan, Matthew J.
    Coffey, Kevin
    Tronnier, Christine D.
    Wang, Donna
    Krase, Kathryn
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2022, 20 (03) : 1814 - 1823
  • [45] Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey
    Cone, David C.
    Bogucki, Sandy
    Burns, Kevin
    D'Onofrio, Gail
    Hawk, Kathryn
    Joseph, Daniel
    Fiellin, David A.
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (06) : E369 - E371
  • [46] Drug use treatment during COVID-19 pandemic: community-based services in Nigeria
    Nelson, Ediomo-Ubong Ekpo
    Dumbili, Emeka W.
    Odeigah, Ogochukwu Winifred
    JOURNAL OF SUBSTANCE USE, 2021, 26 (04) : 391 - 396
  • [47] Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review
    Hannah M. Layman
    Ingibjorg Eva Thorisdottir
    Thorhildur Halldorsdottir
    Inga Dora Sigfusdottir
    John P. Allegrante
    Alfgeir Logi Kristjansson
    Current Psychiatry Reports, 2022, 24 : 307 - 324
  • [48] Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies
    Satre, Derek D.
    Iturralde, Esti
    Ghadiali, Murtuza
    Young-Wolff, Kelly C.
    Campbell, Cynthia, I
    Leibowitz, Amy S.
    Sterling, Stacy A.
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (06) : E293 - E296
  • [49] ACCESS TO HARM REDUCTION TREATMENT AMONG FORMERLY INCARCERATED INDIVIDUALS DURING THE COVID-19 ERA
    Rowell-Cunsolo, Tawandra L.
    Bellerose, Meghan
    Hart, Carl
    HEALTH SECURITY, 2021, 19 : S95 - S101
  • [50] Is substance use changing because of the COVID-19 pandemic? Conceptual and methodological considerations to delineating the impact of the COVID-19 pandemic on substance use and disorder
    Jager, Justin
    Keyes, Katherine M.
    ADDICTION, 2021, 116 (06) : 1301 - 1303